Cargando…

Pulmonary hypertension in congenital heart disease

Pulmonary hypertension is defined as a mean pulmonary arterial pressure ≥25 mmHg. We focus on its relevance in congenital heart disease, reviewing pathophysiology, diagnosis and management. Pulmonary hypertension is a relatively common complication of congenital heart disease, with adult prevalence...

Descripción completa

Detalles Bibliográficos
Autores principales: Pascall, Emma, Tulloh, Robert MR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136120/
https://www.ncbi.nlm.nih.gov/pubmed/29792339
http://dx.doi.org/10.2217/fca-2017-0065
_version_ 1783354939857174528
author Pascall, Emma
Tulloh, Robert MR
author_facet Pascall, Emma
Tulloh, Robert MR
author_sort Pascall, Emma
collection PubMed
description Pulmonary hypertension is defined as a mean pulmonary arterial pressure ≥25 mmHg. We focus on its relevance in congenital heart disease, reviewing pathophysiology, diagnosis and management. Pulmonary hypertension is a relatively common complication of congenital heart disease, with adult prevalence between 5 and 10%. A multifactorial cause is recognized, relating to the size and nature of cardiac defect as well as environmental and genetic factors. More complex disease is increasingly recognized rather than pure Eisenmenger complex. Remodeling of the pulmonary vascular bed causes increased pulmonary vascular resistance diagnosed by a collection of investigations including echocardiography, exercise testing, cardiac catheterization, MRI and CT scanning. Management employs disease-modifying medications which are now used with increasing benefit.
format Online
Article
Text
id pubmed-6136120
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-61361202018-09-21 Pulmonary hypertension in congenital heart disease Pascall, Emma Tulloh, Robert MR Future Cardiol Review Pulmonary hypertension is defined as a mean pulmonary arterial pressure ≥25 mmHg. We focus on its relevance in congenital heart disease, reviewing pathophysiology, diagnosis and management. Pulmonary hypertension is a relatively common complication of congenital heart disease, with adult prevalence between 5 and 10%. A multifactorial cause is recognized, relating to the size and nature of cardiac defect as well as environmental and genetic factors. More complex disease is increasingly recognized rather than pure Eisenmenger complex. Remodeling of the pulmonary vascular bed causes increased pulmonary vascular resistance diagnosed by a collection of investigations including echocardiography, exercise testing, cardiac catheterization, MRI and CT scanning. Management employs disease-modifying medications which are now used with increasing benefit. Future Medicine Ltd 2018-07 2018-05-24 /pmc/articles/PMC6136120/ /pubmed/29792339 http://dx.doi.org/10.2217/fca-2017-0065 Text en © 2018 Professor Robert Tulloh This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Review
Pascall, Emma
Tulloh, Robert MR
Pulmonary hypertension in congenital heart disease
title Pulmonary hypertension in congenital heart disease
title_full Pulmonary hypertension in congenital heart disease
title_fullStr Pulmonary hypertension in congenital heart disease
title_full_unstemmed Pulmonary hypertension in congenital heart disease
title_short Pulmonary hypertension in congenital heart disease
title_sort pulmonary hypertension in congenital heart disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136120/
https://www.ncbi.nlm.nih.gov/pubmed/29792339
http://dx.doi.org/10.2217/fca-2017-0065
work_keys_str_mv AT pascallemma pulmonaryhypertensionincongenitalheartdisease
AT tullohrobertmr pulmonaryhypertensionincongenitalheartdisease